They have already started arriving at the plant in Sewer Derivatives Chemicals has the first components of the new Regenerative Thermal Oxidizer (RTO).
This new equipment, 12 meters high and 120 tons, represents an investment of 2.5 million euros and, besides being built specifically for the needs of the Murcia plant, is the only of its existing properties in Spain .
Just as planned, the first trailers have started these days to unload their merchandise before the August 5 Chemical Derivatives production stops to proceed with the installation of the new RTO.
It is planned that three weeks are used in construction work, so that from August 29 to begin the phase adjustment, calibration and verification of new equipment.
So on September 5, the new machine is fully operational and cominece factory activity.
Technically, the new equipment will operate at 1,100 degrees for two seconds instead of 960 degrees for one second, as it has requested the Directorate General of Public Health.
With a camera that has twice the current size, it will continue as before registering and sending real-time to the Ministry data -11,520 8 minute each day- allowing technicians Regional Government have continuous and comprehensive information on technical activity of the factory and complete environmental safety conditions.
The new RTO will replace the Derivatives Chemicals installed in 2011 and has led, according to the director of the plant, Juan Carlos Garcia, "a huge investment effort to adapt scrupulously to the rules, conditions and technical requirements required by the Integrated Environmental Authorization".
The German company Olpidürr has been commissioned to design the new RTO, specifically designed to meet the legal requirements of the Region of Murcia.
Olpidürr is present in 28 countries, has nearly 15,000 employees and has manufactured more than 1,500 regenerators offering the guarantees of the most advanced technology currently available in the market for the processes of purification of gas emissions generated in the production of active pharmaceutical ingredients (API).
The company Olon, belonging to the Italian pharmaceutical holding P & R, acquired in June Infa Group and with it the Derivatives Chemicals company dedicated to the manufacture of basic medicines and food components.
Olon has five production plants in northern Italy where more than 800 people work.
In renewing its derivatives production equipment Chemical has invested 4 million euros over 2016, a figure likely to rise to 5 million by 2017 to 2018. It is also envisaged to expand the workforce over the next few years to reach 220 employees.
Source: Agencias